Evidence map›Paper›PMID 32681453›Full record

Trial reportJournal of cardiovascular translational research2021

Probiotics Supplementation on Cardiac Remodeling Following Myocardial Infarction: a Single-Center Double-Blind Clinical Study.

Jalal Moludi, Somaieh Saiedi, Behzad Ebrahimi, Mohammad Alizadeh, Yaser Khajebishak, Sevda Saleh Ghadimi

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of cardiovascular translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 5 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 5 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. The gut microbiota in thrombosis.Nature reviews. Cardiology · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jalal MoludiSchool of Nutrition Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran. jmoludi@yahoo.com.ORCID http://orcid.org/0000-0002-8333-414X
Somaieh SaiediNutrition Research Center, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Behzad EbrahimiMaragheh University of Medical Sciences, Maragheh, Iran.
Mohammad AlizadehDepartment of Clinical Nutrition, School of Nutrition and Food Sciences, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. mdalizadeh@gmail.com.
Yaser KhajebishakMaragheh University of Medical Sciences, Maragheh, Iran.
Sevda Saleh GhadimiDepartment of Clinical Nutrition, School of Nutrition and Food Sciences, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Tabriz University of Medical Sciences · IRUniversity of Maragheh · IRKermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse cardiac remodeling after myocardial infarction (MI) can lead to the syndrome of heart failure (HF). Recently, changes in gut microbiota composition (dysbiosis) have appeared as a novel candidate that may be linked to the development of CR and HF. The aim of this trial was to evaluate the effects of probiotics administration on attenuating CR in patients with MI. A single-center double-blind placebo-controlled stratified randomized clinical study was conducted in 44 subjects with MI who underwent percutaneous coronary intervention (PCI). Patients were randomly assigned to take, with lunch, either a probiotic capsule containing 1.6 × 10

Indexed as

Gastrointestinal MicrobiomePercutaneous Coronary InterventionVentricular Function, LeftVentricular RemodelingAgedBiomarkersDouble-Blind MethodDysbiosisEchocardiographyHumansIranLacticaseibacillus rhamnosusMiddle AgedMyocardial InfarctionProbioticsRecovery of FunctionBiomarkersCardiac remodelingHeart failureMicrobiomeMyocardial infarctionProbioticsRehabilitation

Identifiers

PMID32681453
OpenAlexW3042325927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.